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ABSTRACT 
LIQUID-LIQUID EXTRACTION PROCESS FOR HIGH EFFICIENCY RAPID 
PURIFICATION OF COPPER RADIONUCLIDES  
 
Annuli Nnenna Princess Okoye, M.S. 
 
 
University of Pittsburgh, 2016 
 
 
According to a new market report published by Transparency Market Research, the global 
market for radiopharmaceuticals was valued at approximately 3.8 billion USD in 2011 and is 
expected to reach 12.2 billion USD by 2018 (2013). Usually, these radiopharmaceuticals consist 
of three major components: 1) a biomolecule (BM) responsible for receptor targeting; 2) a 
bifunctional chelate (BFC) for radionuclide coordination; and 3) a radionuclide for imaging and/or 
radiotherapy. Specific activity (SA) is one of the most important parameters for characterizing the 
quality of radionuclides or radiotracers. In many cases, it is the limiting factor for using 
radiotracers in biological systems, especially when targeting low capacity receptors, or when there 
is a risk of inducing pharmacological side effects. Competition for the low abundance receptors 
can arise not only from unlabeled versions of the tracer molecule, but also from other molecules 
of related structures, such as byproducts from radiolabeling procedures.  Therefore, achieving high 
SA is extremely important for radiopharmaceuticals that target proteins, such as tumor receptors, 
that are present in very low (nM or less) concentrations in vivo (Woods, Wiseman et al. 1980, 
Velikyan, Beyer et al. 2004, Velikyan, Beyer et al. 2008, Patil, Gada et al. 2012, Zeng, Lee et al. 
 v 
2012). However, one of the major barriers to improving the effective Specific Activity of 
radiometals is contamination from a variety of non-radioactive metal contaminants. In addition to 
optimizing radiolabeling reactions and/or separation methods, removing the metal contaminants 
from radiometals is a direct and efficient approach to increasing the effective SA of metal-based 
radiotracers. A water oil separation device was created for the purpose of purifying Cu-64, for the 
application of the preparation of promising radiopharmaceutical compounds for diagnosis and 
radiotherapy.  The membrane utilized in the device is capable of separating the aqueous solution 
from the organic solvent. Based on the data obtained from UV-Vis spectroscopy of the separated 
two phases that contain different colored dyes, the purity of either the water or the organic phase 
separated by the membrane is greater than 99 %. 
 
 
 
TABLE OF CONTENTS 
PREFACE ..................................................................................................................................... X 
1.0 INTRODUCTION ........................................................................................................ 1 
1.1 MOLECULAR IMAGING: POSITRON EMISSION TOMOGRAPHY ...... 4 
1.1.1 Antibody based Positron Emission Tomography....................................... 6 
1.2 COPPER 64 .......................................................................................................... 7 
1.2.1 Properties of Copper 64................................................................................ 8 
1.2.2 Current Methods of Production. ............................................................... 10 
1.2.3 Current Methods of Purification. .............................................................. 11 
1.2.4 Methods of quantifying metal impurities ................................................. 12 
1.2.5 Selective extraction ..................................................................................... 12 
1.2.6 Chelator  ...................................................................................................... 13 
2.0 MATERIALS AND METHODS .............................................................................. 15 
2.1 WATER-OIL SEPARATION DEVICE .......................................................... 15 
2.1.1 Silicon Membrane Holder  ......................................................................... 15 
2.1.2 3-D Printed Membrane Holder ................................................................. 17 
2.2 FUNCTIONALIZING THE MEMBRANE .................................................... 18 
2.2.1 Flow rate studies  ........................................................................................ 19 
2.2.2 Capacity studies   ........................................................................................ 20 
2.2.3 System optimization studies   ..................................................................... 20 
3.0 RESULTS AND DISCUSSION ................................................................................ 22 
3.1 PRELIMINARY STUDIES .............................................................................. 22 
3.2 CAPACITY AND FLOWRATE STUDIES  ................................................... 23 
3.3 SYSTEM OPTIMIZATION STUDIES  .......................................................... 25 
3.3.1 Dye extraction studies  ................................................................................ 25 
4.0 CONCLUSION ........................................................................................................... 28 
5.0 FUTURE WORK ....................................................................................................... 29 
5.1 CHELATON STUDY ........................................................................................ 29 
APPENDIX  ................................................................................................................................. 31 
BIBLIOGRAPHY ....................................................................................................................... 33 
 vii 
 LIST OF TABLES 
Table 1. Physical Decay Characteristics of the Cyclotron-Produced Conventional PET 
Radionuclides ...................................................................................................................... 6 
Table 2. Physical Properties of Copper Radionuclides for Imaging and Therapy .......................... 9 
 
 
 
 viii 
 LIST OF FIGURES 
Figure 1. Normal PET Imaging  . ................................................................................................... 5 
Figure 2. Effect of pH on the percentage of metal ions extracted by EHPA  . ............................. 14 
Figure 3. Final setup of the structure in which future modifications were modeled after and 
innovated upon .................................................................................................................. 16 
Figure 4. (A) SolidWorks model of the water oil separation device   (B) 3-D printed image of the 
water-oil separating device . ............................................................................................. 17 
Figure 5. Functionalize membrane with an oleophobic area and a hydrophobic area. Red fluid 
depicts the organic phase and the blue fluid depicts the aqueous phase ........................... 18 
Figure 6. Schematic of the flow rate studies experiment .............................................................. 19 
Figure 7. Shows the carrying capacity of the membrane. 7a. shows the carrying capacity of the 
oleophilic membrane. 7b. shows the carrying capacity of the hydrophilic membrane. .... 24 
Figure 8. Shows the effect of flow rate on the separation process ............................................... 24 
Figure 9. Figure depict the extraction study of the fluorine tagged dye ....................................... 26 
Figure 10. Depicts the Red O dye extraction studies (A)Shows the solution with particles of 
undissolved Red O dye  (B) Two phase system depicting the initial phase of Red O 
dissolving in toluene  (C) Emulsion forms in the organic phase after sonication  (D) Red O 
completely in the organic phase (toluene) after the solution has been  centrifuged ......... 27 
Figure 11. a) Complex of EHPA with Copper and b) Schematic of the purification process of 
copper ................................................................................................................................ 30 
Figure 12. Shows the membrane inserted into the holding structure ............................................ 31 
Figure 13. Variations of structures that were designed as a means to test the effect of the platform 
width and channel size to determine which parameter is optimal .................................... 31 
Figure 14. The Plasma Cleaner used in cleaning the surface of the polymer used to create the 
holding structure in this experiment. ................................................................................ 32 
 ix 
Figure 15. The SolidWorks Model of the ideal holding structure that will be implemented in the 
next stage of the design. .................................................................................................... 32 
 
 x 
 PREFACE 
This thesis is ultimately based on a proof of concept for a technology/technique that will require 
quantitative analysis to account for the efficiency of the process.  Qualitative research was carried 
out to ensure that the concept behind this research was feasible and plausible for future students to 
carry it out.  
I would like to thank my mentors Dr. Gao and Dr. Zeng for all they taught me and 
especially for their patience with me during my transition from a PhD student to a Master student. 
I especially want to thank the post doctorate student in Dr. Gao’s lab, Dr. Jiamin, for all the 
relentless help he gave me. He was a kind hearted individual and I wish him God’s blessings on 
his future endeavors.   I would like to thank my family: Mommy and Daddy Okoye, Afoma Okoye 
and Ujunwa Okafor, friends: Bolanle Odusanya, Elizabeth Adewale, Natasha Mishkova and my 
Love, Kolawole Daramola; for their endless support while I was in school. I am surrounded by 
great friends and family members and I thank God for that. I appreciate their prayers, 
encouragement and love. “A friend loves at all times, and a brother is born for a time of adversity” 
(Proverbs 17:17). I especially want to thank God for Jesus Christ and the Holy Spirit because 
without God working in me and around me, I would be nothing. John 15:5 Jesus is the vine and I 
am the branch, apart from him I can do nothing.    
 1 
 
1.0  INTRODUCTION 
Positron emission tomography (PET) is a clinically applicable non-invasive technique for imaging 
the expression of successful gene transduction in specific organs of the human body. PET imaging 
could be used to define the magnitude, location and persistency of gene therapy in the human body 
(Blasberg and Tjuvajev 2003).  PET can aid in studying the effects of cancer therapy in the human 
body, and can be used as a tool to indicate whether or not a certain treatment is successful. 
Therefore, PET plays a vital role in properly diagnosing cancer or verifying suspected recurrences. 
Antibodies labeled with position emitting isotopes are preferable for PET due to the improved PET 
sensitivity (Anderson, Connett et al. 1992). Currently F-fluorodeoxyglucose FDG is one of the 
major radiotracers being used in the application of PET. The preparation of these PET 
radiopharmaceuticals is highly demanding. It requires precise manipulations due to the short half-
life (18F, t1/2= 110 min), as well as an expensive automated apparatus and highly skilled personnel 
(Blasberg and Tjuvajev 2003).  Another limitation of this current radiotracer is the molecule size. 
FDG is a small molecule, therefore it is easily taken up by benign lesions (inflammatory 
processes), and because FDG isn’t as site specific, there are physiological variations with the 
distribution of FDG in the human body (Kircher, Hricak et al. 2012). PET- FDG has been studied 
to quantify the sensitivity, specificity and accuracy. Results showed that PET-FDG has a 
sensitivity of 89-100%, specificity of 69-100% and accuracy of 89-100% (Kircher, Hricak et al. 
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2012). Due to the issue of specificity of the FDG radiotracer, there is a need for a site-specific 
radiotracer.  
Introduction of highly specific activity reactors and accelerator-produced isotopes has led 
to radionuclides being in demand. The office of Isotopes for Medicine and Research (OIMS) 
instituted a network of large reactors around the world (The virtual Isotope Center, VIC) for the 
production of radionuclides in high demands on a yearly basis (Srivastava and Dadachova 2001).  
These factors contribute to the radionuclide being readily available for use in research for further 
understanding. 
In the last decade research has been carried out to study the advancing field of radionuclide 
therapy. This field is quickly growing due to improved bioengineering vehicles for delivering 
radionuclides to tumors (Srivastava and Dadachova 2001). Some radionuclides that can be applied 
in PET are zirconium-89 (t1/2= 78.4 h), bromine-76 (t1/2 = 16.1 h), iodine-124 (t1/2 = 4.15 d), copper-
64 (t1/2 = 12.7 h) (Anderson, Connett et al. 1992).  
64Cu is the radionuclide of interest for the 
purpose of this research, due to its intermediate half-life and its emission characteristics (Toyota, 
Hanafusa et al. 2012). 64Cu has a β- of 37.1% and β+of 17.9%, due to its excellent solubility in 
water, 64Cu is a potential for a radiotracer. High yield of  64Cu increased and high specific activities 
can be achieved, using biomedical cyclotrons to generate the radionuclide (Matarrese, Bedeschi et 
al. 2010). 64Cu can also be produced using a reactor, therefore, it can be readily available for use 
(Anderson, Connett et al. 1992). Anderson et al concluded that there is a viability of 64Cu in the 
use of diagnosing colon cancer. This shows promise for the radionuclide if further studies can be 
completed with the radionuclide. When it comes to the application of 64Cu, there is a need for the 
purification of the products of the cyclotron-produced radionuclide. This is because Fe3+, Zn2+, 
Ni2+, Co2+ and non-radioactive Cu2+ are some of the major transition metal impurities that come 
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from the cyclotron-produced 64Cu. If 64Cu is not properly purified, the impurities may be harmful 
to human health. It will affect the labeling process for the application of 64Cu as a radiotracer  
(Zeng, Lee et al. 2012).  
With the increased availability of medical cyclotrons and improvements in cyclotron 
production, the use of “non-standard” radionuclides has also increased accordingly (Anderson and 
Welch 1999, Lewis, Welch et al. 2008, Zeng and Anderson 2013). Among those “non-standard” 
radionuclides, copper radionuclides, including 60Cu, 61Cu, 62Cu, 64Cu and 67Cu, attract increased 
interest due to the broad applications in diagnostic imaging, radiotherapy and theranostics (Novak-
Hofer and Schubiger 2002, Wadas, Wong et al. 2007, Anderson and Ferdani 2009, Smith, Bowers 
et al. 2012). The use of copper radionuclides presents a number of advantages, including: (i) copper 
is limited to two principle oxidation states (I and II) and the coordination and redox chemistry are 
well documented, (ii) the biochemistry and metabolism of copper is also well known; and (iii) 
long-term targeting and trapping is made feasible, due to the physical properties of the available 
isotopes which leads to the development of kinetically inert copper complexes (Zeng, Desai et al. 
2013).  Among the different copper radionuclides, 64Cu with suitable decay characteristics is the 
most commonly utilized copper isotope for PET imaging. In addition, due to its 39% β- emission, 
64Cu has also been used for targeted radiotherapy.   
In this proposal, 64Cu will be investigated as proof-of-concept study to validate the 
proposed purification strategy. Currently, 64Cu is produced via the 64Ni(p,n)64Cu reaction on a 
biomedical cyclotron, and processing of the enriched 64Ni target involves the dissolution of the 
nickel into 6 M HCl, cooling of the dissolved nickel solution, recovery of the nickel via ion 
chromatography, followed by elution of 64Cu from the resin with 0.5 M HCl (McCarthy, Shefer et 
al. 1997).. However 64Cu obtained from such purification usually still contains a significant amount 
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of transition metal contaminants: Fe3+, Ni2+, Cu2+, Co2+ and Zn2+, as established by various analytic 
methods (Watanabe, Watanabe et al. 2009, Zeng, Lee et al. 2012, Zeng and Anderson 2013). 
Therefore by using a fluorous-tagged pyridinecarboxylic acid (PDA) extract, a highly efficient 
liquid-liquid extraction is proposed for the rapid purification of copper radionuclides. In addition, 
Dr. Zeng recently developed LC-MS quantification technology (Zeng and Anderson 2013) to 
quantify the overall effectiveness/purity of the process in this proposal.  
1.1 MOLECULAR IMAGING: POSITRON EMISSION TOMOGRAPHY  
Molecular imaging in oncology can be defined as “in vivo characterization and 
measurement of the key biomolecules and molecularly based events that are fundamental to the 
malignant state” (Kircher, Hricak et al. 2012). Molecular imaging plays a vital role in cancer 
management. Molecular imaging is a vital tool for cancer detection, staging, and assessment of 
effectiveness of the cancer treatment (tumor response, and etc.).  Molecular imaging is a tool with 
the capacity to improve upon multiple aspects of cancer care. PET is a molecular imaging tool that 
characterizes and detects tumors based on molecular alterations (Kircher, Hricak et al. 2012).  
Images depicting the cancerous sites are obtained from PET through the decay emission detected 
by the instrument as shown in Figure 1. 18F-fluorodeoxyglucose (FDG) is injected into the human 
body. FDG takes advantage of the Warburg effect. One of the characteristics of cancer cells is 
increased glucose metabolism and the conversion of glucose carbon to lactate. Increased glucose 
metabolism is due to the glucose transporters (gluT) increased expression and activity as well as 
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changes in the glycolytic enzyme expression and activity (Kircher, Hricak et al. 2012). Images are 
obtained via the detection of the positrons emitted by the radionuclide in the organ being studied.   
 
  
Figure 1. Normal PET Imaging (Miele, Spinelli et al. 2008) 
 
There are direct imaging strategies and indirect imaging strategies. Positron Emission 
Tomography (PET) with the use of FDG to image falls under the direct imaging strategies. Table 
1. depicts the properties of the radionuclide 18F.  FDG PET is based on the activity of the enzyme 
hexokinases (Blasberg and Tjuvajev 2003).The utilization of radionuclides with short half-lives 
has its disadvantages. There are advantages of the utilization of radionuclides such as 18F- FDG 
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that have been widely studied and are currently approved of for the application in PET. One of the 
advantages is that the use of these radionuclides results in minimizing doses of exposure to the 
clinicians and patients. Also, multiple imaging studies can be carried out in the same day due to 
the short half-lives of the radionuclides, so the patient does not have to remain in the hospital 
overnight for the studies to be carried out (Holland, Williamson et al. 2010). However, due to the 
short half live (rapid decay) of the radionuclide, there are limits to the chemistry in regards to its 
use for radiopharmaceutical research. Radionuclides with emission of auger electrons and β- or α-
particles are potential radionuclides for the design of radionuclide agents. Potential for future 
production of chemically identical agents for imaging and site directed radiotherapy exist for a 
variety of elements for which PET/therapeutic radionuclide pairs exist.  
 
Table 1. Physical Decay Characteristics of the Cyclotron-Produced Conventional PET 
Radionuclides (Holland, Williamson et al. 2010). 
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1.1.1 Antibody based Positron Emission Tomography  
Mesothelin (MSLN) is a protein-coding gene that is overexpressed in a wide range of cancers. 
MSLN is found in a majority of cancers such as: ovarian cancers, pancreatic adenocarcinomas, 
epithelial mesotheliomas, lung adenocarcinomas, gastric cancers, triple-negative breast cancers, 
uterine serous carcinoma, acute myeloid leukemia, cholangiocarcinoma, pancreatic 
adenocarcinomas, and in 100% of epithelial mesotheliomas. Due to the limited distribution of 
MSLN in normal tissues as well as its elevated expression in cancers, MSLN has great potential 
to be a suitable target for cancer diagnosis and therapy by using the specific antibodies for MSLN 
and the well-established coordination chemistry of copper. Copper-64 can be reacted using a 
chelator to the specific antibody for MSLN and thereby can be utilized in an antibody based 
Positron Emission Tomography system (Kobayashi, Sasaki et al. 2015). 
1.2 COPPER 64 
Copper offers a variety of radionuclides for imaging and radionuclide therapy. The various copper 
isotopes undergo β-, electron capture and positron decay, which make them of great interest.  The 
variety of copper isotopes ranges from copper-60, copper-61, copper-62, copper-64, copper-66, 
copper-67.  Copper radioisotopes have versatile characteristics like those of transition elements of 
47 on the periodic table due to its range of oxidation states. In regards to the abundance of metals 
in the human body, after iron and zinc, copper is the third abundant metal in the human body. Due 
to its abundance in the human body, research and understanding of its pathways are known. This 
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information is vital for application of copper related systems in radiopharmaceuticals (Blower, 
Lewis et al. 1996). 
1.2.1 Properties of Cu-64 
The radioisotope of interest for this research is Cu-64.  It has a half-life of 12.7 h, with an electron 
capture (41%) β- (40%) and β+ (19%) decays as well as auger electron emission with therapeutic 
potential. The half-life of Cu-64 tolerates for a sufficient time for radiopharmaceuticals synthesis 
of many complexes. Table 3. Shows the properties of many copper isotopes in which Cu-64 is one 
of the most versatile isotopes.  Interest in Cu-64 increased due to the high yield and high specific 
activities from typical biomedical cyclotron (Blower, Lewis et al. 1996). 64Cu has decent solubility 
in water with an oxidation state of +2 (CuCl2) (Kim, Park et al. 2009). 
64Cu  has strong chelating 
properties which is advantageous for labeling biomolecules through stable coordination complexes 
in formation with bifunctional chelators (Le, Howse et al. 2009). One of the many applications of 
Cu-64 is its potential use in PET as a radiotracer (Blower, Lewis et al. 1996). Based on the 
proposed application for which the radionuclide is intended for, it determines how the radionuclide 
or therapeutic agent is chosen. The diagnostic method is the deciding factor for choosing the 
radionuclide to work with (Holland, Williamson et al. 2010). 
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Table 2.  Physical Properties of Copper Radionuclides for Imaging and Therapy. Ep – Energy of 
the most abundant penetrating (γ) radiation following the corresponding Enp Average Energy of 
the most abundant penetrating (β+/β- ) radiation. Rnp – Average range of the non-penetrating 
radiation in tissue (Blower, Lewis et al. 1996). 
 
Radioimmunotherapy (RIT) is a methodology that incorporates the use of antigen specific 
monoclonal antibodies (mAb) or mAb-derived reagents in an effort to deliver therapeutic 
radionuclides to tumor (Srivastava and Dadachova 2001). Studies have been carried out and 64Cu-
labeleled monoclonal antibodies are possible by the chelation of the mAb via a bifunctional 
chelator. Copper in itself binds weakly to proteins; therefore there is a need for a bifunctional 
chelator. The chelator will bond covalently to the antibody while also forming a strong bond with 
the copper (Anderson, Connett et al. 1992). Molecules like 18F (half-life: 109.77 m) and 68Ga (half-
life: 67.71 m) would not be ideal for labeling due to their short half-lives in merely 2 – 3 hours.  
Their short half-lives would mean the activity of the radionuclides would have reduced 
significantly before optimal distribution of the radiotracer in the biological system. Elements such 
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as 52Mn (half-life: 5.591 days) and 74As (half-life: 17.77 days) won’t be ideal for mAb labeling 
due to their extensive half-lives, which would take more than a day to decay, and would result in 
relatively poor counting statistics for PET and increase patient exposure to a higher radiation dose 
(Holland, Williamson et al. 2010) . 
1.2.2 Current methods of production 
64Cu can be obtained from nuclear reactor such as 63Cu(n,γ)64Cu which relates to thermal neutron 
capture reaction. The radionuclide can also be obtained from a fast neutron reaction  64Zn(n,p)64Cu 
(McCarthy, Shefer et al. 1997). 64Cu can be obtained from proton irradiation that is carried out in 
a medical cyclotron 64Ni(p,n)64Cu, 64Ni(d,2n)64 (Kim, Park et al. 2009). The production of 64Cu in 
regards to availability is readily available at the reactor sites but the specific activity of the resulting 
radioisotope is too low therefore, it cannot be used for labeling antigens or receptor targeted 
compounds. The high or low activity of the production of  64Cu by reactor is dependent on whether 
the production is carried out by direct activation (n,γ) or indirectly through (n,p) on a Zn target 
(Blower, Lewis et al. 1996). Though the utilization of  fast neutrons in the  reactor results in 64Cu 
with high specific activity, the 64Cu is not readily available, which makes using it not as feasible 
and time and cost intensive (Blower, Lewis et al. 1996). 
The preferred method of 64Cu preparation is via biomedical cyclotron (McCarthy, Shefer 
et al. 1997). The irradiation of enhanced 64Ni target carried out in a cyclotron results in the highest 
specific activity in comparison to the reactor produced 64Cu (Blower, Lewis et al. 1996). What is 
currently in use for the production of 64Cu, is 64Ni target and 68Zn target. The 68Zn(p,α,n) allows 
for the production of both 64Cu and 67Ga and the target is cheaper in comparison to the 64Ni target. 
 11 
 
But this method results in a product that requires radiochemical separation that is complex with a 
high contamination probability from a variety of radionuclide impurities. Also, the 64Cu yield from 
the 68Zn target is preferential. The alternative cyclotron method advantage is that the reaction 
requires a low proton energy (<15MeV) in comparison to the alternative, which requires (30 MeV). 
The 64Cu from the 64Ni target is higher in yield and has a lower potential for impurities due to the 
fact that the reaction pathway results in fewer side reactions. Its disadvantages are that the process 
requires enriched 64Ni target, which is expensive, and it’s not as applicable when using a larger 
cyclotron. The larger weight of the 64Ni makes the process ineffective due to the cost and the need 
to design a target specific system (Le, Howse et al. 2009). 
1.2.3 Current methods of purification  
As previously stated, in order to effectively utilize the radionuclide, contamination has to be 
minimized. The contaminants compete with the Cu-64 while producing the radiotracer, especially 
nickel. If applied to a human subject, the nickel increases the stress on the human body and may 
cause various types of acute and chronic disorders. These disorders affect the liver, lung and kidney 
and include the following: gastrointestinal distress, pulmonary fibrosis, and renal edema. Cu-64 
separation from a nickel target is usually separated by the means of solvent extraction, 
precipitation, electro plating and ion exchange. Ion exchange is widely used because unlike the 
other methods, it eliminates the need for added carriers (Fan, Parker et al. 2006). Most ion 
exchange methods utilize a base anion exchanger. Cation exchangers are not utilized due to the 
selectivity coefficient of the cation exchangers being very close to that of metal ions of the same 
charge. While ion exchange in general may lead to the use of fewer chemicals in comparison to 
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solvent extraction, the process also has its limitations. Anion exchange uses a high degree of 
chemicals and after separation; there is a high content of residual nickel in the radioactive product 
stream, which is harmful to human health. There is a need for a method that reduces the amount 
of residual nickel in the product stream, specifically a method that purifies Cu-64 with a purity of 
> 99 % (Fan, Parker et al. 2006). 
1.2.4 Methods of quantifying metal impurities  
Radiometals are known to have a significant amount of metal impurities that at specific levels 
impedes the radiolabeling. Impurities must be minimized to achieve high specific activity. High 
specific activity is important for imaging agents that target proteins. Dr. Zeng Research Group has 
identified the Liquid Chromatography Mass Spectroscopy as an effective means to quantify non-
radioactive metal contaminants and also as a means to determine Effective Specific Activity for 
the chelator of interest, thereby resulting in an optimized relabeling condition (Zeng and Anderson 
2013). 
1.2.5 Selective extraction  
Solvent extraction, in conjunction with chelators, is used in an array of fields. Commercial 
chelating entrants are readily available and are used in combination with organic diluents. A 
concern in using liquid-liquid extraction is the environmental impact of the use of a high volume 
of volatile organic diluents. The use of a membrane aids in the minimization of the use of organic 
solvents. Alkylated pyridinecarboxylic acid derivatives play a major role in separation chemistry; 
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one major reason for this is that the carboxylic acid group is present on the chelator.  (Tasaki, 
Oshima et al. 2007) 
1.2.6 Chelator  
Successful purification of copper 64 is dependent on extraction of copper from the bulk aqueous 
solution of metal ions. A selective chelator is key to successfully extracting copper (a preferential 
chelator is one with an affinity for copper and the organic phase over the aqueous phase). A 
potential candidate is EHPA (A (N-6-(2-ethylhexylamido) - 2pyridinecarboxylic acid).  Separation 
of copper (II) can be carryout using EHPA at a low pH (acidic environment). As seen in Figure 2, 
95.5% extraction of copper (II) was carried out at a pH of about 2.90, based on the preliminary 
data by Tasaki et al. Based on the experimental results, it is likely that the alkyl amide group does 
not participate in the formation of a complex with copper (II). The formation of the EHPA copper 
(II) complexes is hypothesized to be via the pyridine moiety and carboxylic acid (to form a five 
membered ring). The affinity for EHPA for divalent metals (Cu >> Zn ≈ Pb ≈ Ni ≈ Co ≈ Cd ≈ Mn) 
can be explained using Pearson’s HSAB (Hard, Soft, Acid, Base) concept.  EHPA’s greater affinity 
for copper (II) is due to copper’s ability to form a tetra-coordinate geometry which is a neutral 
complex in comparison to the octahedral coordinate complex that other metals such as Zn, Co and 
Mn form with EHPA (Tasaki, Oshima et al. 2007). 
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Figure 2 Effect of pH on the percentage of metal ions with EHPA. 
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2.0  MATERIALS AND METHODS 
For the purpose of this research, lab experiments were carried out in Dr. Gao’s lab located on the 
9th floor of Benedum within the chemical engineering department at the University of Pittsburgh. 
Occasionally, some experiments, such as the Ultraviolet visible (UV-Vis) spectroscopy studies, 
and test for solvent soluble dye, were carried out in Dr. Zeng’s lab located within the Center for 
Biotechnology and Bioengineering, fourth floor of the bridge side building located within the 
University of Pittsburgh.  
2.1 WATER-OIL SEPERATION DEVICE  
2.1.1 Silicon Membrane Holder  
The structure used to house the membrane was designed using SYLGARD® 184 SILICONE 
ELASTOMER KIT.  
1. 10:1 Parts of the polymer were mixed and then placed in a desiccator for approximately 2 
hours until there were no more bubbles.  
2. The mixed polymer was placed into a mold and heated at 80℃ on a hot plate for 
approximately an hour, then allowed to cool down. 
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3. The mixed polymer was placed into a mold and heated at 80℃ on a hot plate for 
approximately an hour, then allowed to cool down.  
4. The pieces needed to create the designs were cut from the polymer block (Figure 3). 
5. The pieces were cleaned using ethanol and dried using Nitrogen gas.  
6. The surface of the cut pieces was further cleaned using Plasma Cleaner / Sterilizer PDC 32 
G (Figure 14.) for 30 seconds and then immediately the pieces were joined together and 
placed in the oven for 20 – 30 minutes to ensure adhesion. Figure 2B depicts the final 
holding membrane made from the silicone. 
 
 
Figure 3. Final setup of the structure in which future modifications were modeled after and innovated upon.
Solution of 
water and oil  
Channel 
Membrane 
Collection 
Vial  
 17 
 
2.1.2 3-D printed Membrane Holder  
SolidWorks Model was implemented in the design of the membrane-holding device. Figure 4A 
depicts the drawing of the holding device utilized as a holding chamber for the membrane utilized 
in the experiments discussed further in this paper. The device was 3-D printed at the Swanson 
Center for Product Innovation located at the University of Pittsburgh.  Figure 4B illustrates the 3-
D printed device and its functionality.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4. (A) SolidWorks model of the water oil separation device   (B) 3-D printed image of the water-oil separating 
device. 
 
A B 
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2.2 FUNCTIONALIZING THE MEMBRANE  
The membrane utilized in the separating device, was functionalized using two commercially 
available products named No. 1 and No. 3. Half of WhatmanTM Filter Paper 3 (CAT No. 1003-
055) was functionalized by hand dipping the filter paper in the hydrophobic solution (No.1) and 
then immediately being placed in an oven at 85℃ overnight. Then the other half was hand dipped 
in the hydrophilic solution (No.3) and placed in an oven set at 85℃ overnight. Figure 5 is the 
image of the functionalized membrane.  
 
 
Figure 5. Functionalize membrane with an oleophobic area and a hydrophobic area. Red fluid depicts the organic 
phase and the blue fluid depicts the aqueous phase. 
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2.2.1 Flow Rate Studies  
After functionalizing the membrane used for this study, then the solutions were prepared. The 
aqueous solution was made by dissolving 10 mg of water-soluble dye, methylene Blue  
(CAS 7220-79-3) in 10 ml of nano-pure water. The organic solution was made by dissolving 12.5 
mg oil-soluble dye, red O (CAS 1320-06-5) in 12 ml of toluene. Figure 6 depicts the lab setup for 
how the various studies were carried out.  
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Schematic of the flow rate studies experiments. 
 
Membrane.  
Red side: Oleophilic  
Blue side: Hydrophilic  
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2.2.2 Capacity Studies  
Membrane capacity studies were carried out by having a fully oleophobic functionalized 
membrane and a fully hydrophobic functionalized membrane of various sample areas: 22.9, 8, 6, 
4, 2, 1, .25 cm2. Each membrane was fully saturated and the weight difference was tracked for 
each type of membrane.  
 
2.2.3 System Optimization Studies  
A series of dyes made in Dr. Zeng’s lab were tested. The purpose was to determine the proper dye 
that is partially soluble in the aqueous phase (1:9, Dimethyl sulfoxide (DMSO) : nano-pure water) 
but has an affinity for the organic phase (toluene). The dye being tested was dissolved initially in 
DMSO in a vial and then diluted with water. Then an organic phase was added to the vial and 
agitated using a sonicator. The emulsified solution was separated by the use of a centrifuge. The 
determining factor to verify if the dye was extracted in the organic phase was observed via a color 
change in the organic phase. 
Procedures followed:  
 First emulsifying a solution of toluene and the water-dye mixture in a glass vial. 
 Let the solution sit unperturbed for a few minutes. 
 Extract the parts of the solution that are not emulsified (using a pipette). 
 Run the emulsified part of the solution through the functionalized paper towel.  
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o Test the hydrophobic paper towel and the oleophobic paper towel. (This will help 
isolate whether or not the functionalized paper is breaking the emulsion or 
absorbing the solution. This will also help determine if what the emulsion consists 
of in regards to whether it’s purely toluene or water.
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3.0  RESULTS AND DISCUSSION 
Findings from these experiments as stated in the preface were mostly qualitative data that requires 
further intensive study to properly quantify and qualify the effectiveness of the system through the 
use of liquid Chromatography, mass spectroscopy, ultraviolet visible spectroscopy studies. This 
work did confirm the efficiency of the membrane in separating the aqueous solution from the 
organic solvent. Based on the data obtained from UV-Vis spectroscopy of the separated two phases 
that contain different colored dyes, the purity of either the water or the organic phase separated by 
the membrane is greater than 99 %.   
3.1 PRELIMINARY STUDIES RESULT  
Human error significantly affects the effectiveness of the design in respect to separating the water 
and oil.  If the polymer does not adhere to each other properly and there is a slight leak anywhere, 
the oil substance will make its way all over the structure, which indirectly affects the results. The 
membrane has to be saturated before separation will take place at a lower flow rate (50 ≤flow rate 
<100 ul/min). As the flow rate increases ( 100 ≤flow rate  ≤200 ul/min⁡) the size of the platform 
seems to play a major role in separation.  
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At a higher flow rate the solution races down the membrane faster and at impact on the platform, 
it either falls to the left or the right side into the appropriate channel (minimizing the platform will 
reduce the effect of liquid going into the wrong channel). In regards to designing the 3-D model, 
some of the takeaways from the preliminary studies were: the structure has to be at an acute angle, 
45 ° – 85° would work. But the difference in the degree is hard to observe due to the lack of 
repeatable results.  
3.2 CAPACITY AND FLOWRATE STUDIES  
Results from the studies showed that the functionalized hydrophilic membrane in general had a 
greater carrying capacity than that of the oleophilic membrane. Therefore, during the flow rate 
studies we expected to have the organic phase drop first before the aqueous phase. But this was  
not what was observed. This can be attributed to the fact that the hydrophilic membrane had a 
greater wettability than the oleophilic membrane. This resulted in a faster absorbance of the 
aqueous phase into the membrane, as seen in Figure 7. These findings resulted in a shift from the 
commercial solvent number 3 to a different product (FBL035) as a means to functionalize the 
membrane and make it oleophilic. The new product proved to be more effective and resulted in a 
similar wettability in the oleophilic membrane as the hydrophilic membrane.  
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Figure 7.  (a) Shows the carrying capacity of the membrane hydrophilic membrane. (b) Shows the carrying capacity 
of the oleophilic membrane.  
 
Flow rate has an effect on separation speed. As the flow rate increases, the time needed to 
carry out the separation decreased as presented in Figure 8. Based on the data obtained from 
ultraviolet–visible spectroscopy (UV-Vis) of the separated two phases that contain different 
colored dyes, it was determined that the purity of either the water or the organic phase separated 
by the membrane is greater than 99 %.  This led to the conclusion that flow rate only had an effect 
on the speed of the process but not the effectiveness.  
 
A. B. 
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Figure 8. Shows the effect of flow rate on the separation process 
 
3.3 SYSTEM OPTIMIZATION STUDIES   
In this study we found that there is no need to use a dual functionalized membrane system. 
Commercial paper towels were functionalized and a new system was employed.  
3.3.1 Dye Extraction Studies    
Studies carried out to test the fluorine tagged dye with the hydrophilic functionalized paper towels 
showed that the emulsified phase is indeed an aqueous phase and the emulsified liquid is not being 
broken up by the fictionalized membrane, as seen in Figure 9.   Running the emulsified solution 
mixed with toluene through the membrane does not result in extraction of the dye from the 
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emulsified solution into the organic phase. The proper way to ensure extraction is to first centrifuge 
the solution before running it through the functionalized membrane. The fluorine tagged dye, even 
after being centrifuged, was not extracted into the organic phase. There was a faint color change, 
which is indicative of slight solubility of the fluorine tagged dye in the organic phase.  
 
Figure 9. Figure depict the extraction study of the fluorine tagged dye 
 
If a centrifuge step is not carried out, in order to break the emulsion and extract the dye into the 
organic phase, a different method needs to be employed to separate the emulsion. The red O dye 
was tested and was partially soluble in DMSO and after being sonicated and then centrifuged, the 
red O was successfully extracted into the organic phase as seen in Figure 10.  
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Figure 10. Depicts the Red O dye extraction studies (A) Shows the solution with particles of undissolved Red O dye  
(B) Two phase system depicting the initial phase of Red O dissolving in toluene  (C) Emulsion forms in the organic 
phase after sonication  (D) Red O completely in the organic phase (toluene) after the solution has been centrifuged 
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4.0  CONCLUSION 
Thus far we have a proven system that is able to separate oil and water with a high efficiency.  The 
next phase of this research will be in the utilization of this separation technique to separate Copper 
(II) from a solution of Fe3+, Ni2+, Cu2+, Co2+ and Zn2+ by combining the use of fluorine-tagged 
PDA derivatives with the membrane-based separation process. The proposed fluorine-tagged PDA 
derivatives will be synthesized by coupling 2-pyridinecarboxylic acid with commercially available 
fluorous alcohol, and the resulting fluorine-tagged PDA derivatives will be tested at various pH 
and solvent modification ratios to find the optimal chelator as well as the optimal conditions 
(concentrations and solvent ratio s) for copper extraction. Once success has been made in 
extracting non-radioactive copper from the transition metals that exist in the cyclotron-produced 
64Cu, we will test the efficiency of our technique by using copper radionuclides. The metal 
contaminants in 64Cu before and after the proposed purification process will be quantified by using 
the LC-MS approach developed by Dr. Zeng’s research group (Zeng and Anderson 2013). 
Automation of this liquid-liquid process will lead to lower radiation doses for radio chemists. It 
will reduce cross-contamination risks and overall it will lead to a more efficient purification 
method compared to a solid phase extraction process. 
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5.0  FUTURE WORK 
A comprehensive understanding of copper isotopes has not yet been fully met. Thus far the 
chemistry of copper that has been studied is limited to the chelators and functionality/ complexes 
of the ligands studied (Blower, Lewis et al. 1996). Better understanding of the copper isotopes, 
especially copper 64, is needed so that research, such as the research carried out in this paper by 
Tasaki et al, can be specifically designed in order to ensure that the system is optimized for 
enhanced copper 64 performance. 18F-FDG PET imaging has been the utilized for over 20 years, 
therefore the introduction of a new radiotracer (Blasberg and Tjuvajev 2003) will need to be a 
well-defined and validated model that will perform well above the current radiotracer by being site 
specific with enhanced images.  
5.1 CHELATION STUDY 
Based on preliminary research carried out by Tasaki et al, PDA derivative, EHPA (N-6-(2-
ethylhexylamido)- 2pyridinecarboxylic acid) will be used in the extraction of copper into the 
organic phase (Tasaki, Oshima et al. 2007) while other transition metals will remain in the aqueous 
phase under strong acidic conditions (pH=2). The extracted copper can be further released into the 
aqueous under strong acidic conditions (pH<2).  As seen in Figure 10A, with a 
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coordination number of 6, the pyridine moiety and carboxylic acid play a vital role in the EHPA 
chelation of copper. The objective of my research is to develop an automated liquid-liquid 
extraction process for high-efficiency rapid purification of copper radionuclides by combining the 
use of a fluorine-tagged PDA extractant with a membrane-based water-oil separation process. The 
process comprises 3 steps as shown by Figure 10B. : (i) chelate copper radionuclides with fluorine-
tagged PDA in aqueous solution at moderate acidic conditions (pH>2), (ii) extract chelated copper 
radionuclides from aqueous phase to organic phase, and (iii) release copper radionuclides from 
fluorine-tagged PDA in organic phase back into aqueous phase under strong acidic condition (pH 
<2). In both the 2nd and the 3rd steps, the organic phase and the aqueous phase will be separated by 
using a membrane to facilitate the automation process.  
 
 
 
 
Figure 11. a) Complex of EHPA with Copper and b) Schematic of the purification process of copper. 
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APPENDIX 
PRELIMINARY RESULTS 
Appendix includes images from the preliminary studies carried out to optimize the membrane-
carrying device for the water-oil separation process.  
 
 
 
 
 
 
Figure 12. Shows the membrane inserted into the holding structure 
 
 
 
 
 
 
 
 
Figure 13. Variations of structures that were designed as a means to test the effect of the platform width and channel 
size to determine which parameter is optimal.  
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Figure 14. The Plasma Cleaner used in cleaning the surface of the polymer used to create the holding structure in this 
experiment.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. The SolidWorks Model of the ideal holding structure that will be implemented in the next stage of the 
design.  
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